|

PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).

RECRUITINGN/ASponsored by Centre Hospitalier Universitaire de Liege
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire de Liege
Started2022-10-27
Est. completion2025-05-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05602259

Summary

This prospective study will examine eosinophils in various biological materials to compare the detection in those materials and ascertain the prognostic and predictive role of eosinophils in untreated non-small cell lung cancer patient.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* o All stages of NSCLC

  * Stage III-IV NSCLC eligible for ICI treatment
  * 18 years or older; non pregnant women
  * in stage III-IV: no previous ICI and before ICI (mono- or combination therapy) initiation
  * Signed informed consent
  * Clinical, biological and radiological evaluation at the CHU de Liège for at least 6 months following treatment initiation

Exclusion Criteria:

* Probable noncompliance with the follow-up requirements of the study (psychiatric condition, socio-economic factors)
* Inclusion in a clinical study contraindicating the enrolment in the PROTEON study

Conditions3

CancerLung CancerNon Small Cell Lung Cancer

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.